People co-infected with HIV and HCV, mostly with hepatitis C virus (HCV) genotype 3, responded about as well as HIV-negative people to interferon-based therapy after taking into account other factors associated with poor treatment response, according to an Italian study presented at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) this month in Denver. Advanced liver fibrosis was common in the co-infected group, supporting the need for early treatment.
October 1, 2013
Treating HCV genotypes 2 and 3 in HIV/HCV co-infected people
Research and Markets: PharmaFocus: HIV - R&D Strategies towards Cure and Prevention
September 27, 2013
Young woman living with HIV urges international community not to drop guard on HIV
Barbara Martinez, a young Ecuadorian activist living with HIV, urged the international community not to drop its guard on HIV during her address at the 68th United Nations General Assembly special event on the Millennium Development Goals (MDGs). The event was convened to review progress towards the MDGs as well as to discuss the transition into the post-2015 development framework.
HIV and the immune system linked to heart disease in women
The widespread availability of potent combination anti-HIV therapy (commonly called ART or HAART) in Canada, Australia, the U.S. and Western Europe has greatly improved the health of HIV-positive people. Deaths from AIDS-related infections are now much less common, at least among HIV-positive people who get tested, make regular clinic visits and take ART every day exactly as directed.
September 24, 2013
International momentum builds to expand access to antiretroviral therapy
HIV scientists, doctors, and health economists have gathered in London on 22-24 September to present the clinical and financial case for HIV treatment and other HIV prevention activities to achieve the 2015 global AIDS targets. Under the title Controlling the HIV Epidemic with Antiretrovirals: From Consensus to Implementation, more than 400 delegates considered data about how the latest HIV prevention programmes work.
September 23, 2013
Global Fund Results Show Dramatic Gains
UNAIDS reports a 52% reduction in new HIV infections among children and a combined 33% reduction among adults and children since 2001
A common side effect of HIV and AIDS, neurocognitive impairment, may be overlooked due to inadequate screening
One of the common side effects of HIV and AIDS is neurocognitive impairments - changes in how fast a person can process information, pay attention, multi-task and remember things - yet there are no adequate tests to screen patients for these problems, according to a new study out of St. Michael's Hospital.
September 19, 2013
Does Facebook Help Prevent HIV?
Facebook has been blamed for everything from causing narcissistic behavior to influencing teens to smoke and drink more. But UCLA has revealed that Facebook can also do some good.
In a recent study by UCLA researchers, it was found that using behavioral science methods as well as social media such as Facebook "can lead to improved health behaviors among men at risk of HIV infection."
September 16, 2013
Charlize Theron crusades against AIDS 'devastation'
(CNN) -- At 19 years old she was spotted by a talent agent while engaging in a shouting match with a bank teller in Los Angeles. Since then Charlize Theron has powerfully demonstrated an almost chameleon-like ability to assume the roles she takes on.
Zero new HIV infections among children can be a reality
September 12, 2013
ABC Syringes: No More Reused Syringes!
Every year, scores of people get infected with various diseases because they were injected using unsterile and reused syringes. It’s unfortunate but it happens more often than you think. Case in point: according to the World Health Organization, 5% of all new HIV cases, 32% of all Hepatitis B cases, and 40%of Hepatitis C cases are caused by unsafe injections.
September 11, 2013
Experts meet on advancing access to HIV treatment
Experts call for increased access to life-saving HIV treatment. The call, made during a meeting held in New York on 4-5 September, follows the recommendations made last year by the independent Global Commission on HIV and the Law on improving access to HIV treatment.
The Global Commission’s landmark report recommended a new intellectual property framework for pharmaceuticals that would meet urgent public health needs while safeguarding the rights of inventors.
August 29, 2013
Scientists Say Claims of HIV Cure "Within Months" Misleading
It has been nearly half a year since news sources inaccurately reported that Danish scientists were "within months" of finding a cure for HIV for their ongoing, and as-yet-unpublished, research of histone deacetylase (HDAC) inhibitors. Although a cure is not on the immediate horizon, the Danish vaccine trial continues to look at HDAC inhibitors -- and even a cancer drug -- as a means to flush HIV from the viral reservoir, where it hides from antiretrovirals even during successful therapy.
HIV Cure: 5 Lethal Diseases Associated with AIDS, Effective Treatments/Study Progress
HIV researchers are working round-the-clock searching for an effective treatment and cure against HIV infection. However, some people are just too stubborn and continue risky behaviour even with the global threat of the virus. Know the five lethal associated diseases with AIDS and their treatments currently being researched by medical experts.
It is essential to treat pediatric AIDS in the elimination agenda
Scott Kellerman and colleagues argue that the scope of the current HIV elimination agenda must be broadened in order to ensure access to care and treatment for all children living with HIV.
In 2011, despite the global initiative to eliminate mother-to-child transmission of HIV, 330,000 new pediatric infections were added worldwide to the existing pool of 3.4 million children living with the virus.
August 27, 2013
UNITAID launches first-ever comprehensive report on HIV prevention products
Shows promise to curb transmission if high prices can be reduced.
The rate of new HIV infections in adults and adolescents has not fallen since 2007 but an unprecedented range of new products to prevent transmission of the disease could reduce the 2.5 million new HIV infections each year if they are made affordable, according to a report released today by UNITAID.
August 26, 2013
High proportion of Canadian patients with HIV-HCV co-infection and liver cirrhosis are not having ultrasounds to check for liver cancer
Two patients diagnosed with hepatocellular carcinoma (HCC, liver cancer) did not have ultrasound screens.
August 23, 2013
The Past, Present, and Future of HIV Treatments
HIV, the virus that causes AIDS, has become one of the world's most devastating diseases since it was first recognized more than three decades ago. 33.4 million people across the world are infected with HIV, and 1.15 million of those live in the United States. To date, there is no cure for the disease, which leads to the progressive failure of the immune system, although current treatments are now much more advanced than Retrovir (AZT) -- the first approved HIV medication, which had marginal benefits and a terrible side effect profile.
August 21, 2013
A Closer Look at the Market for Home and Lab HIV Tests
It is often said that the real cure for HIV and AIDS will come from better, more discrete testing procedures, and not from the drug cocktails made by Gilead Sciences, GlaxoSmithKline and Merck. Considering that nearly 20% of individuals infected with HIV aren't even aware that they are carrying the virus, HIV tests should be just as important in battling the virus as condoms or antiviral medications.